Haemonetics Corp
HAE- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000313143
No open-market purchases or sales by Haemonetics Corp insiders were filed in the last 90 days; 330 institutions reported holding it in 13F filings for Q2 2026, worth $3.72B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Haemonetics Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 294
- +30 vs. Q3 2022
- Shares held
- 50.4M
- −1.35M (−2.6%) vs. Q3 2022
- Total value
- $3.96B
- +$132.8M (+3.5%) vs. Q3 2022
- New holders
- 50
- 102 more added
- Sold out
- 20
- 104 more reduced
5 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HAE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 330 | $3.72B |
| Q1 2026 | 324 | $2.68B |
| Q4 2025 | 330 | $4.08B |
| Q3 2025 | 301 | $2.50B |
| Q2 2025 | 300 | $4.05B |
| Q1 2025 | 315 | $3.44B |
| Q4 2024 | 310 | $4.42B |
| Q3 2024 | 306 | $4.49B |
| Q2 2024 | 317 | $4.62B |
| Q1 2024 | 298 | $4.37B |
| Q4 2023 | 295 | $4.33B |
| Q3 2023 | 298 | $4.55B |
| Q2 2023 | 296 | $4.30B |
| Q1 2023 | 302 | $4.17B |
| Q4 2022 | 294 | $3.96B |
| Q3 2022 | 269 | $3.83B |
| Q2 2022 | 242 | $3.39B |
| Q1 2022 | 242 | $3.26B |
| Q4 2021 | 257 | $2.66B |
| Q3 2021 | 246 | $3.58B |
| Q2 2021 | 258 | $3.38B |
| Q1 2021 | 297 | $5.51B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Haemonetics Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −7,998−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −5,451−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −4,772−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −2,996−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −2,850−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −2,818−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,495−100.0% | Sold out |
| Ellis Investment Partners, LLC | 0 | $0 | 0.00% | −912−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −630−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −317−100.0% | Sold out |
| Kenfarb & Co. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Wagner Wealth Management, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Absolute Capital Management, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Walthausen & Co., LLC | – | – | – | – | Not filed |
| Eaton Vance Management | – | – | – | – | Not filed |
| USA Financial Portformulas Corp | – | – | – | – | Not filed |
| FourThought Financial, LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |